Opinion On Allergy Alert Test (AAT) as a proof-of-concept study

Europe – Update – MDCG 2022-13 Rev.1 – Designation, re-assessment and notification of conformity...

This document aims to provide guidance to the authorities responsible for notified bodies (hereafter, the Designating Authorities) and joint assessment teams (JATs) when conducting: − assessments of...
As coronavirus roils region, EU device body adamant about steps to hit MDR deadline

Europe – MDCG 2024-1-5 : Guidance on the vigilance system for CE-marked devices DSVG...

The aim of this Device Specific Vigilance Guidance (DSVG) is to harmonise vigilance reporting and provide guidance for manufacturers of Urogynaecological Surgical Mesh Implants used for...
SCCS - Final Opinion on Solubility of Synthetic Amorphous Silica (SAS)

Europe – Monitoring the Availability of Medical Devices and In Vitro Diagnostic Medical Devices...

Medical devices (MDs) and in vitro diagnostic medical devices (IVDs) are essential for a working healthcare system and play a crucial role in the...

Europe – Annual report 2023

The Management Board’s oversight role covers the full range of EMA programmes and activities, making sure that the Agency works effectively and co-operates successfully...
COVID-19 outbreak: the presidency steps up EU response by triggering full activation mode of IPCR

Europe – Medical devices: Council adopts new measures to help prevent shortages

The Council has adopted new rules updating the law on medical devices in order to help prevent shortages and ease the transition to greater transparency and access to...

Europe – Questions & Answers for applicants, marketing authorisation holders of medicinal products and...

This Question and Answer (Q&A) document provides practical considerations concerning the implementation of the medical devices and the in vitro diagnostic medical devices regulations...
Practical guidance for procedures related to Brexit for medicinal products for human and veterinary use within the framework of the centralised procedure

Europe – MDCG 2022-4 Rev 2 Guidance on appropriate surveillance regarding the transitional provisions...

Article 120 of the Medical Device Regulation (EU) 2017/745 (MDR), as amended by Regulation (EU) 2023/6071, states that devices which are covered by valid...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – MHRA announces consultation on improved safety for high risk in vitro diagnostic...

IVD devices are used to examine samples taken from the human body and to diagnose and monitor health conditions. For example, devices can determine...
NICE grants Lynparza expansion for advanced ovarian cancer

UK – Home testing devices could increase the number of people diagnosed with sleep...

An independent NICE committee has recommended five devices to diagnose and assess the severity of obstructive sleep apnoea hypopnoea syndrome (OSAHS). Around five per cent...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – MHRA announces a proposed framework for international recognition of medical devices

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (21 May 2024) published a statement of policy intent for international recognition of medical devices. The MHRA’s...

NOS PROCHAINES FORMATIONS